Atlas Trials

Sobi, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sobi, Inc.

RecordFirmDate
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP (NCT05369208)Sobi, Inc.2022-06-15
Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months (NCT05046327)Sobi, Inc.2021-10-14
Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim (NCT04638829)Sobi, Inc.2021-03-15
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months (NCT04516967)Sobi, Inc.2021-03-05
Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers (NCT03471078)Sobi, Inc.2018-10-12
Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure (NCT03554759)Sobi, Inc.2018-07-02
Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure (NCT03326843)Sobi, Inc.2018-03-26

Track Sobi, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.